Nutrineal 4 Amino Acids (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

After intraperitoneal injection, the amino acids diffuse across the peritoneal membrane into the systemic circulation. Once in the bloodstream, they become substrates for cellular processes such as protein synthesis, gluconeogenesis, and enzyme production. By directly supplying these building blocks, the mixture helps meet metabolic demands when oral or enteral intake is insufficient.

The prescribed dose of Nutrineal 4 Amino Acids is individualized by the treating clinician based on factors such as the patient’s weight, nutritional status, renal and hepatic function, and overall clinical condition. Healthcare professionals calculate the appropriate amount to achieve targeted amino acid delivery while avoiding excess nitrogen load.

Safety data for Nutrineal 4 Amino Acids in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case carefully and consider alternative nutritional strategies when appropriate.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including cold‑chain handling if needed) and assists with import documentation.

Nutrineal 4 Amino Acids is a comprehensive amino acid formulation designed for intraperitoneal delivery, whereas many alternative products are formulated for intravenous use. Its composition includes a balanced mix of essential and non‑essential amino acids, making it suitable for patients requiring broad-spectrum protein support. Choice of product depends on the clinical route, compatibility with other nutrition components, and institutional protocols.

The solution should be stored at 2‑8 °C (refrigerated). Keep the container in its original packaging, protect it from light, and avoid freezing or shaking. Maintaining the cold‑chain ensures stability of the amino acids and prevents degradation before administration.

Nutrineal 4 Amino Acids is administered via intraperitoneal injection, typically through a peritoneal catheter. The healthcare provider prepares the sterile solution according to aseptic technique, selects the appropriate volume based on the prescribed dose, and infuses it slowly to allow absorption across the peritoneal membrane.

Serious risks include anaphylactic reactions, metabolic acidosis, hepatic dysfunction, and catheter‑related infections such as sepsis. Patients with compromised renal or hepatic function are at higher risk for nitrogen overload and electrolyte disturbances. Continuous monitoring and prompt management of adverse events are essential during therapy.

Nutrineal 4 Amino Acids should be avoided in individuals with known hypersensitivity to any of its amino acid components, severe renal or hepatic impairment where nitrogen clearance is compromised, and in patients with uncontrolled metabolic disorders that could be exacerbated by amino acid infusion. Clinical judgment is required to assess suitability for each patient.